TATUM bioscience

Platform for the development of therapeutically functionalized probiotics

Jean-François Millau
CEO, co-founder
Kevin Neil
CTO, co-founder
Sébastien Rodrigue
CSO, co-founder

TATUM leverages synthetic biology to build a category-defining platform based on engineered phages capable of multitasking immunotherapies to break cancer resistances. This first-in-class modality triggers full-blown antitumor immune responses providing unparalleled clearance efficacy.

Advice for entrepreneurs

“ Stay humble and know how to surround yourself well! ”

– Jean-François Millau

Discover other incubated startups

Here are the companies that are at the heart of each of our decisions and that we are proud to support.

Together, let’s build the world of tomorrow.